FEATURED

Risks, Benefits of Early ADT

Earlier androgen deprivation therapy may increase death risk, but earlier docetaxel may lower it.

Drug Showcase: FARYDAK (panobinostat)

Indicated for relapsed multiple myeloma.

Hyperfiltration May Affect Renal Function

Adaptive hyperfiltration may be more important than structural adaptive hypertrophy for the recovery of renal function following radical nephrectomy.

Immunotherapies in Cancer Treatment

FDA-approved immunotherapies are showing efficacy in different cancer types and combination therapies with new biologics are displaying increased efficacy.

Opioid Dependence and Cancer

There are key factors to consider when determining the best treatment strategy for pain in patients with cancer.

Elderly Head & Neck CA

Research from ASCO indicates treatment of locally advanced head and neck cancer should be carefully considered in patients older than 70.

Predicting Outcomes in RCC

Researchers have zeroed in on factors associated with disease progression and survival in patients treated for renal cell carcinoma.

XTANDI Practice and Patient Resources

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

Functional Adaptive Hyperfiltration May Affect Renal Function after Radical Nephrectomy

Functional Adaptive Hyperfiltration May Affect Renal Function after Radical Nephrectomy

Adaptive hyperfiltration may be more important than structural adaptive hypertrophy for the recovery of renal function following radical nephrectomy.

Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies

Older Adults with Head and Neck Cancers May Need More Cautious Treatment Strategies

Research from ASCO indicates treatment of locally advanced head and neck cancer should be carefully considered in patients older than 70.

Feature Articles

Prostate Cancer Androgen Deprivation and Chemo: Does Timing Matter?

Prostate Cancer Androgen Deprivation and Chemo: Does Timing Matter?

Earlier androgen deprivation therapy may increase death risk, but earlier docetaxel may lower it.

Immunotherapies Shine at ASCO Annual Meeting

Immunotherapies Shine at ASCO Annual Meeting

FDA-approved immunotherapies are showing efficacy in different cancer types and combination therapies with new biologics are displaying increased efficacy.

Featured Videos

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs